Hepatocyte peroxisome proliferator-activated receptor alpha regulates bile acid synthesis and transport
-
Add time:08/08/2019 Source:sciencedirect.com
Peroxisome proliferator-activated receptor alpha (PPARα) controls lipid homeostasis through regulation of lipid transport and catabolism. PPARα activators are clinically used for hyperlipidemia treatment. The role of PPARα in bile acid (BA) homeostasis is beginning to emerge. Herein, Ppara-null and hepatocyte-specific Ppara-null (Ppara∆Hep) as well as the respective wild-type mice were treated with the potent PPARα agonist Wy-14,643 (Wy) and global metabolomics performed to clarify the role of hepatocyte PPARα in the regulation of BA homeostasis. Levels of all serum BAs were markedly elevated in Wy-treated wild-type mice but not in Ppara-null and Ppara∆Hep mice. Gene expression analysis showed that PPARα activation (1) down-regulated the expression of sodium-taurocholate acid transporting polypeptide and organic ion transporting polypeptide 1 and 4, responsible for the uptake of BAs into the liver; (2) decreased the expression of bile salt export pump transporting BA from hepatocytes into the bile canaliculus; (3) upregulated the expression of multidrug resistance-associated protein 3 and 4 transporting BA from hepatocytes into the portal vein. Moreover, there was a notable increase in the compositions of serum, hepatic and biliary cholic acid and taurocholic acid following Wy treatment, which correlated with the upregulated expression of the Cyp8b1 gene encoding sterol 12α-hydroxylase. The effects of Wy were identical between the Ppara∆Hep and Ppara-null mice. Hepatocyte PPARα controlled BA synthesis and transport not only via direct transcriptional regulation but also via crosstalk with hepatic farnesoid X receptor signaling. These findings underscore a key role for hepatocyte PPARα in the control of BA homeostasis.
We also recommend Trading Suppliers and Manufacturers of TAUROHYODEOXYCHOLIC ACID SODIUM SALT (cas 110026-03-4). Pls Click Website Link as below: cas 110026-03-4 suppliers
Prev:ApoE is a major determinant of hepatic bile acid homeostasis in mice
Next:Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid08/15/2019
- Influence of dietary bile acids on formation of bile acids in rat08/14/2019
- Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis08/13/2019
- Therapeutic effects of an oral adsorbent on acute dextran sulphate sodium-induced colitis and its recovery phase in rats, especially effects of elimination of bile acids in gut lumen08/12/2019
- Bile salt deconjugation and BSH activity of five bifidobacterial strains and their cholesterol co-precipitating properties08/11/2019
- Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition08/10/2019
- Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats08/09/2019
- ApoE is a major determinant of hepatic bile acid homeostasis in mice08/07/2019
- Composition and aggregational forms of biliary lipids in human bile after short-term administration of Taurohyodeoxycholic acid08/06/2019
-
Health and Chemical more >


